Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer

Clinical Cancer Research

Volumn 4, Issue 3, 1998, Pages 659-664

  Toi, Masakazu ^a   Taniguchi, Tadaaki ^a   Ueno, Takayuki ^a   Asano, Michio ^a   Funata, Nobuaki ^a   Sekiguchi, Kiyoshi ^b   Iwanari, Hiroko ^b   Tominaga, Takeshi ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b Institute of Immunology Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST DISEASES; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; PREMENOPAUSE; PROGNOSIS; RECURRENCE; REFERENCE VALUES; SEX CHARACTERISTICS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0031899266     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Dickson, R. B., and Lippman, M. E. Growth factors in breast cancer. Endocr. Rev., 16: 55-89, 1995.
2. Oka, T., Tsutsumi, O., Kurachi, H., and Okamoto, S. The role of epidermal growth factor in normal and neoplastic growth of mouse mammary epithelial cells, in: M. E. Lippman and R. Dickson (eds.), Breast Cancer: Cellular and Molecular Biology, pp. 343-362. Boston: Kluwer Academic Publishers, 1988.
3. O'Reilly, M. S., Holmgren, L., Chen, C., and Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med., 2: 689-692, 1996.
4. Favoni, R. E., Cupis, A., and Perrota, A. Insulin-like growth factor-1 (IGF-1) and IGF-binding proteins blood serum levels in women with early- and late-stage breast cancer: mutual relationship and possible correlations with patients hormonal status. J. Cancer Res. Clin. Oncol., 121: 674-682, 1995.
5. Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F., and Folkman, J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. Natl. Cancer Inst., 86: 356-361, 1994.
6. Chakrabarty, S., Huang, S., Moskal, T. L., and Fritsche, H. A. Elevated serum levels of transforming growth factor-α in breast cancer patients. Cancer Lett., 79: 157-160, 1994.
7. Kopp, A., Jonat, W., Schmahl, M., and Knabbe, C. Transforming growth factor β2 (TGF-β2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen. Cancer Res., 55: 4512-4515, 1995.
8. Taniguchi, T., Toi, M., Inada, K., Imazawa, T., Yamamoto, Y., and Tominaga, T. Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin. Cancer Res., 1: 1031-1034, 1995.
9. Nakamura, T., Nawa, K., and Ichihara, A. Partial purification and characterization of hepatocyte growth factor from serum of hepatomized rats. Biochem. Biophys. Res. Commun., 122: 1450-1459, 1984.
10. Weidner, K. M., Arakaki, N., Hartmann, G., Vandekerckhove, J., Weingart, S., Rieder, H., Fonatsch, C., Tsubouchi, H., Hishida, T., Daikuhara, Y., and Birchmeier, W. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc. Natl. Acad. Sci. USA, 88: 7001-7005, 1991.
11. Rosen, E. M., Nigam, S. K., and Goldberg, I. D. Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction. J. Biol. Chem., 127: 1783-1787, 1994.
12. Nakamura, T. Structure and function of hepatocyte growth factor. Prog. Growth Factor Res., 3: 67-85, 1991.
13. Bussolino, F., Di Renzo, M. F., Ziehe, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A., and Comoglio, P. M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol., 119: 629-641, 1992.
14. Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., Nickoloff, B. J., Kinsella, J. L., Polverini, P., and Rosen, E. M. Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sci. USA, 90: 1937-1941, 1993.
15. Yamashita, J., Ogawa, M., Yamashita, S., Nomura, K., Kuramoto, M., Saishoji, T., and Shin, S. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res., 54: 1630-1633, 1994.
16. Tuck, A. B., Park, M., Sterns, E. E., Boag, A., and Elliott, B. E. Coexpression of hepatocyte growth factor and receptor (met) in human breast carcinoma. Am. J. Pathol., 148: 225-232, 1996.
17. Seslar, S., Nakamura, T., and Byers, S. W. Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors. Cancer Res., 53: 1233-1238, 1993.
18. Yamada, A., Matsumoto, K., Iwanari, H., Sekiguchi, K., Kawata, S., Matsuzawa, Y., and Nakamura, T. Rapid and sensitive enzymelinked immunosorbent assay for measurement of HGF in rat and human tissues. Biomed. Res., 16: 105-114, 1995.
19. Toi, M., Inada, K., Suzuki, H., and Tominaga, T. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res. Treat., 36: 193-204, 1995.
20. Peto, R., and Peto, J. Asymptotically efficient rank invariant test procedures. J. R. Stat. Soc.,(A) 135: 185-207, 1972.
21. Cox, D. R. Analysis of Binary Data. London: Methuen, 1970.
22. Rosen, P. P. Tumor emboli in intramammary lymphatics in breast carcinoma: pathological criteria for diagnosis and clinical significance. Pathol. Annu., 18: 215, 1983.
23. Roses, D. F., Bell, D. A., Flotte, T. J., Taylor, R., Ratech, H., and Dubin, N. Pathologic predictors of recurrence in Stage I (TlNOMO) breast cancer. Am. J. Clin. Pathol., 78: 817-820, 1982.
24. Jeffers, M., Rong, S., Anver, M., and Woude, G. F. V. Autocrine hepatocyte growth factor/scatter factor-met signaling induces transformation and the invasive/metastatic phenotype in C127 cells. Oncogene, 13: 853-861, 1996.
25. Bellusci, S., Moens, G., Gaudino, G., Comoglio, P., Nakamura, T., Thiery, J-P., and Jouanneau, J. Creation of an hepatocyte growth factor/ scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene, 9: 1091-1099, 1994.
26. Kuniyasu, H., Yasui, Y., Yokozaki, H., Kitadai, Y., and Tahara, E. Aberrant increase of c-met mRNA in human gastric carcinomas. Int. J. Cancer, 55: 72-75, 1993.
27. Furukawa, T., Duguid, W. P., Kobari, M., Matsuno, S., and Tsao, M-S. Hepatocyte growth factor and met receptor expression in human pancreatic carcinogenesis. Am. J. Pathol., 147: 889-895, 1995.
28. Joseph, A., Weiss, G. H., Jin. L., Fuchs, A., Chowdhury, S., O'Shaugnessy, P., Goldberg, I. D., and Rosen, E. M. Expression of scatter factor in human bladder carcinoma. J. Natl. Cancer Inst., 87: 372-377, 1995.
29. Tsarfaty, I., Resau, J. H., Rulong, S., Keydar, I., Faletto, D. L., and Vande Woude, G. F. The met proto-oncogene receptor and lumen formation. Science (Washington DC), 1257: 1258-1261, 1992.
30. Huguet, E. L., Smith, K., Bicknell, R., and Harris, A. L. Regulation of Wnt5a mRNA expression in human mammary epithelial cells by cell shape, confluence, and hepatocyte growth factor. J. Biol. Chem., 270: 12851-12856, 1995.
31. Mars, W. M., Zarnegar, R., and Michalopoulos, G. K. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am. J. Pathol., 143: 949-958, 1993.
32. Naldini, L., Tamagnone, L., Vigna, E., Sachs, M., Hartmann, G., Birchmeier, W., Daikuhara, Y., Tsubouchi, H., Blasi, F., and Comoglio, P. M. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J., 11: 4825-4833, 1992.
33. Shimomura, T., Miyazawa, K., Komiyama, Y., Hiraoka, H., Naka, D., Morimoto, Y., and Kitamura, N. Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur. J. Biochem., 229: 257-261, 1995.
34. Taniguchi, T., Toi, M., and Tominaga, T. Rapid induction of hepatocyte growth factor by heparin. Lancet, 344: 470, 1994.
35. Tsubouchi, H., Niitani, Y., Hirono, S., Nakayama, H., Gohda, E., Arakaki, N., Sakiyama, O., Takahashi, K., Kimoto, M., Kawakami, S., Setoguchi, M., Tachikawa, T., Shin, S., Arima, T., and Daikuhara, Y. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology, 13: 1-5, 1991.
36. Eagles, G., Warn, A., Ball, R. Y., Baillie-Johnson, H., Arakaki, N., Daikuhara, Y., and Warn, R. M. Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients. Br. J. Cancer, 73: 377-381, 1996.
37. Taniguchi, T., Kitamura, M., Arai, K., Iwasaki, Y., Yamamoto, Y., Igari, A., and Toi, M. Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. Br. J. Cancer, 75: 673-677, 1997.
38. Yamamoto, Y., Toi, M., Kondo, S., Matsumoto, T., Suzuki, H., Kitamura, M., Tsuruta, K., Taniguchi, T., Okamoto, A., Mori, T., Yoshida, M., Ikeda, T., and Tominaga, T. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin. Cancer Res., 2: 821-826, 1996.